Midie Xu

4.4k total citations
111 papers, 2.6k citations indexed

About

Midie Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Midie Xu has authored 111 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 45 papers in Cancer Research and 41 papers in Oncology. Recurrent topics in Midie Xu's work include Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (19 papers) and Ferroptosis and cancer prognosis (18 papers). Midie Xu is often cited by papers focused on Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (19 papers) and Ferroptosis and cancer prognosis (18 papers). Midie Xu collaborates with scholars based in China, United States and Japan. Midie Xu's co-authors include Weiwei Weng, Weiqi Sheng, Cong Tan, Shujuan Ni, Xiang Du, Yong Wu, Dan Huang, Qiongyan Zhang, Ping Wei and Meng Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Midie Xu

99 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Midie Xu China 29 1.6k 1.3k 709 471 244 111 2.6k
Jianfei Huang China 31 1.6k 1.0× 866 0.7× 761 1.1× 313 0.7× 159 0.7× 96 2.5k
Mu-Yan Cai China 33 1.7k 1.1× 965 0.7× 735 1.0× 473 1.0× 471 1.9× 58 2.9k
Gregor Krings United States 27 1.2k 0.8× 813 0.6× 825 1.2× 438 0.9× 464 1.9× 62 2.8k
Yinghui Guan China 22 1.5k 0.9× 1.1k 0.9× 876 1.2× 490 1.0× 186 0.8× 54 2.6k
Céline Callens France 27 1.0k 0.7× 740 0.6× 670 0.9× 480 1.0× 217 0.9× 83 2.2k
Shujuan Ni China 24 2.2k 1.4× 2.1k 1.6× 550 0.8× 309 0.7× 235 1.0× 61 2.9k
Tomoya Sudo Japan 25 2.6k 1.7× 2.3k 1.8× 616 0.9× 402 0.9× 376 1.5× 74 3.5k
Eri Arai Japan 30 1.5k 1.0× 597 0.5× 427 0.6× 446 0.9× 326 1.3× 78 2.2k
Shiu‐Feng Huang Taiwan 29 1.4k 0.9× 596 0.5× 1.2k 1.7× 944 2.0× 327 1.3× 78 2.9k
Hui‐Zi Chen United States 12 1.4k 0.9× 774 0.6× 1.1k 1.6× 656 1.4× 377 1.5× 25 2.6k

Countries citing papers authored by Midie Xu

Since Specialization
Citations

This map shows the geographic impact of Midie Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Midie Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Midie Xu more than expected).

Fields of papers citing papers by Midie Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Midie Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Midie Xu. The network helps show where Midie Xu may publish in the future.

Co-authorship network of co-authors of Midie Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Midie Xu. A scholar is included among the top collaborators of Midie Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Midie Xu. Midie Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Longchao, Yahui Zhang, Jianchun Li, et al.. (2025). A review on in-situ monitoring of the temperature field in metal-based laser additive manufacturing. Measurement Science and Technology. 36(11). 112001–112001.
4.
Ye, Shiqi, Jian‐Feng Xiang, Siqi Zhou, et al.. (2025). Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF‐κB and TGF‐β Signaling Pathways. Advanced Science. 13(8). e18500–e18500.
5.
Yu, Yingyan, et al.. (2024). Structure-aware deep model for MHC-II peptide binding affinity prediction. BMC Genomics. 25(1). 127–127. 5 indexed citations
6.
Liu, Yingxue, Xiaoyan Zhang, Wenchao Gu, et al.. (2024). Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: Mechanisms and therapeutic prospects. Journal of Advanced Research. 71. 399–413. 29 indexed citations
8.
Li, Na, Xiaochen Lu, Midie Xu, et al.. (2023). Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression. Nature Metabolism. 5(7). 1159–1173. 50 indexed citations
9.
Xu, Midie, Xing Zhang, Kexin Su, et al.. (2023). Gambogenic acid inhibits proliferation and ferroptosis by targeting the miR‐1291/FOXA2 and AMPKα/SLC7A11/GPX4 axis in colorectal cancer. Cell Biology International. 47(11). 1813–1824. 17 indexed citations
11.
Wang, Ziliang, Wei Chen, Ling Zuo, et al.. (2022). The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells. Cancer Communications. 42(3). 245–265. 101 indexed citations
12.
Wang, Xu, et al.. (2022). The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer. Cell Death and Disease. 13(10). 874–874. 58 indexed citations
13.
Gan, Lu, Qingguo Li, Wei Nie, et al.. (2022). PROX1-mediated epigenetic silencing of SIRT3 contributes to proliferation and glucose metabolism in colorectal cancer. International Journal of Biological Sciences. 19(1). 50–65. 8 indexed citations
14.
Yang, Yufei, Lingfang Xia, Yong Wu, et al.. (2021). Programmed death ligand‐1 regulates angiogenesis and metastasis by participating in the c‐JUN/VEGFR2 signaling axis in ovarian cancer. Cancer Communications. 41(6). 511–527. 42 indexed citations
15.
Wang, Xin, et al.. (2021). Effects of CAF-Derived MicroRNA on Tumor Biology and Clinical Applications. Cancers. 13(13). 3160–3160. 26 indexed citations
16.
Xu, Midie, et al.. (2020). MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway. SHILAP Revista de lepidopterología. 4 indexed citations
17.
Ren, Fu‐de, Weiwei Weng, Qi Zhang, et al.. (2019). Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases. SHILAP Revista de lepidopterología. 4 indexed citations
18.
Huang, Dan, Shujuan Ni, Cong Tan, et al.. (2019). Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity. Cancer Cell International. 19(1). 310–310. 21 indexed citations
19.
Xu, Yu, Wei Sun, Biqiang Zheng, et al.. (2019). DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis. Experimental Cell Research. 379(1). 48–54. 30 indexed citations
20.
Wu, Yong, Yu Deng, Jun Zhu, et al.. (2018). Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer. Cell Death and Disease. 9(9). 861–861. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026